Bill & Melinda Gates Foundation

Leinco Technologies develops and supplies high-purity monoclonal antibodies, recombinant proteins, and related reagents for diagnostics, biopharmaceutical research, and flow cytometry. The company focuses on monoclonal antibody development, in vitro production of antibodies and proteins, antibody conjugations, and associated services, including cell banking, optimization, and adaptation, to support early discovery programs and the development of protein therapeutics.

Founded in 2014, Micron Biomedical is a clinical-stage biopharmaceutical company based in Atlanta, Georgia. It specializes in developing microneedle patches for vaccines, aiming to enhance protective effects and patient compliance while simplifying administration.

BioSurfaces is a developer of medical devices specializing in tissue engineering and personal care products. The company leverages advanced electrospinning technology to produce nanofibrous materials that facilitate controlled drug delivery and enhance healing at the implant site. By utilizing a room-temperature electrospinning process, BioSurfaces enables the integration of drug loading within each fiber, creating a reservoir for sustained drug release. This innovative approach allows for the creation of devices and coatings as thin as 10 micrometers, making it possible to treat diseases directly at the site of implantation. The company aims to provide next-generation solutions for the medical and personal care markets, focusing on improving patient outcomes through effective disease treatment and tissue regeneration.

La Ruche Health connects patients with virtual and at-home healthcare services via its AI-driven platform. It offers advice through text, voice, and images, facilitating easy booking of medical appointments and lab tests via iOS, Android, and WhatsApp.

ApiJect is a medical technology company that provides a platform for creating scalable prefilled injectors and performing fill-finish of injectable drugs. The platform can operate on its own Blow-Fill-Seal lines or with manufacturing partners, enabling broad adoption of prefilled, single-dose injections. The technology replaces glass, aluminum, rubber, and silicone with medical-grade plastic resin, simplifying the supply chain and reducing environmental impact. By enabling pharma and biotech companies to produce affordable medicines and vaccines, ApiJect helps deliver safe, widely accessible injectable therapies to more patients.

Noze specializes in digital odor perception technology, aiming to replicate the human sense of smell digitally. Utilizing advanced machine learning and an innovative sensor based on NASA technology, Noze detects and identifies odors with precision. Their primary goal is to improve patient outcomes by enabling real-time disease detection through breath-based biomarkers at any point-of-care.

Owlstone Medical develops and commercializes breathalyzers for clinical diagnostics and precision medicine. Its products detect volatile organic compounds in breath samples to diagnose diseases like lung cancer, asthma, and tuberculosis. The company has strategic collaborations with pharmaceutical companies and is based in Cambridge, UK.

Owlstone Medical develops and commercializes breathalyzers for clinical diagnostics and precision medicine. Its products detect volatile organic compounds in breath samples to diagnose diseases like lung cancer, asthma, and tuberculosis. The company has strategic collaborations with pharmaceutical companies and is based in Cambridge, UK.

Sibel Health develops wearable, clinical-grade digital health monitoring solutions for hospital and research use. The company focuses on wireless vital signs monitoring through soft, flexible sensors that are portable and user-friendly, enabling accurate data capture in clinical settings and during clinical trials. Its technology includes chest monitoring and limb sensors that measure heart rate, respiratory rate, skin temperature, body position and activity, supported by a physiological monitoring platform with analytics for both clinical care and research applications. The wearables are designed for neonatal care in the NICU as well as broader healthcare and pharmaceutical research contexts, offering biocompatible, silicone-based devices. The company aims to improve patient outcomes by providing continuous, real-time monitoring and data integration to support care decisions and study outcomes.

Noze specializes in digital odor perception technology, aiming to replicate the human sense of smell digitally. Utilizing advanced machine learning and an innovative sensor based on NASA technology, Noze detects and identifies odors with precision. Their primary goal is to improve patient outcomes by enabling real-time disease detection through breath-based biomarkers at any point-of-care.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Naobios is a contract development and manufacturing organization (CDMO) located in Saint Herblain, France. The company specializes in bioprocess development and offers good manufacturing practice (GMP) production services for clinical batches of various biological products, including viral vaccines, oncolytic viruses, viral vectors, and challenge agents. With expertise in optimizing production processes, Naobios supports the development of live vaccine products, contributing to advancements in biopharmaceutical manufacturing.

LTS is a leading pharmaceutical technology company that develops and manufactures innovative drug delivery systems such as Transdermal Patches ("TTS"​) and Oral Thin Films ("OTF"​) for the pharmaceutical industry. While we continuously refine our TTS and OTF technologies further, we also research complementary Micro Array Patches for the transdermal delivery of large molecule, biological actives. Incorporated in 1984, we operate today from two sites in Andernach, Germany and West Caldwell/NJ, USA, plus representative office in Shanghai/China.

Founded in 2014, Micron Biomedical is a clinical-stage biopharmaceutical company based in Atlanta, Georgia. It specializes in developing microneedle patches for vaccines, aiming to enhance protective effects and patient compliance while simplifying administration.

Philips is a global technology company focused on health technology and improving people’s health and well-being through meaningful innovation. It offers a broad portfolio spanning diagnostic imaging, ultrasound, image-guided therapy, patient monitoring, health informatics, and consumer health products, as well as home care devices. The company operates across three segments—diagnosis and treatment, connected care, and personal health—and also develops lighting and consumer electronics for everyday use. Philips serves hospitals, clinics, and homes, applying advanced technologies to support prevention, diagnosis, treatment, and home-based care while pursuing sustainable, user-centered solutions.

GE Healthcare specializes in medical technology, offering a wide range of products including medical imaging systems, information technologies, diagnostics, patient monitoring devices, and biopharmaceutical manufacturing solutions. With a global presence, they aim to enhance patient care and outcomes through innovative healthcare solutions.

Co-Diagnostics, Inc. is a molecular diagnostics company based in Salt Lake City, Utah, founded in 2013. The company specializes in the development, manufacture, and marketing of advanced diagnostic technologies that focus on the detection and analysis of nucleic acid molecules, such as DNA and RNA. In addition to creating reagents for diagnostic tests, Co-Diagnostics offers self-contained lab systems that incorporate diagnostic equipment from other manufacturers. The company also leverages its proprietary technology to design targeted tests for identifying genetic markers, which can be utilized in various industries beyond infectious diseases, while licensing these tests to specific customers.

Latham BioPharm Group provides insight, knowledge, and a network to unite teams and technologies in the life sciences. It offers consulting across vaccine, therapeutic, medical device, and diagnostic product development, including business development, program management, CMC, quality, regulatory, and strategic guidance. The team averages more than 20 years of experience and includes former executives at startups and Fortune 200 companies, with some having government experience. Over more than two decades, the firm has helped clients identify, evaluate, fund, manage, and monetize opportunities in diverse segments, generating government funding and licensing investments. Its services cover strategy and portfolio analysis, market research, and commercial and government asset analysis to inform decisions and connect with target markets. It also assists in securing funding through business development and non-dilutive funding services and moves programs toward value inflection points via program management and product development teams.

Hyperfine is a pioneering medical device company that developed Swoop®, the world's first FDA-cleared point-of-care MRI system. Designed to enhance patient access to critical care, Swoop produces high-quality images rapidly and at a lower cost than conventional MRIs, enabling clinicians to diagnose and treat patients swiftly in various clinical settings.

Noze specializes in digital odor perception technology, aiming to replicate the human sense of smell digitally. Utilizing advanced machine learning and an innovative sensor based on NASA technology, Noze detects and identifies odors with precision. Their primary goal is to improve patient outcomes by enabling real-time disease detection through breath-based biomarkers at any point-of-care.

UW Medicine is a clinical research and healthcare system that provides a higher degree of healthcare for pre-med students. UW Medicine health professionals provide the most up-to-date care for each individual patient through these integrated programs, lead one of the world's largest and most comprehensive medical research programs, and provide innovative learning programs for students, trainees, and practitioners in the health professions. UW Medicine, as the region's only comprehensive clinical, research, and learning health system, provides a higher level of healthcare, ranging from primary and preventive care to the most highly specialized care for the most complex medical conditions.

LumiraDx Ltd, incorporated in 2016 and based in London, United Kingdom, is a next-generation point-of-care diagnostics company. It specializes in manufacturing an innovative diagnostic platform that provides a wide range of tests with lab-comparable performance. LumiraDx aims to transform healthcare by offering solutions that facilitate integrated, patient-centered care, enhancing safety, efficiency, and health outcomes. The company's diagnostic system includes a portable instrument, low-cost test strips, and seamless digital connectivity, making diagnostic-led care simpler and more accessible. LumiraDx operates in multiple countries, including the United States, Italy, Germany, and Sweden, with a significant portion of its revenue generated from the U.S. market.

Aspen Pharmacare is a global pharmaceutical company that manufactures and supplies branded, generic, and specialty medicines across over 150 countries. Its portfolio includes general anaesthetics, muscle relaxants, anticoagulants, and other therapeutic areas. Aspen also offers contract manufacturing services for active pharmaceutical ingredients and finished dose forms.

Bayer is a global life science company specializing in healthcare and agriculture. It focuses on developing and commercializing products and solutions based on scientific knowledge, with core competencies in pharmaceuticals, consumer health, and crop science.

Nuvisan is a global provider of pharmaceutical research services, based in Neu-Ulm, Germany. The company operates as a fully integrated contract research organization (CRO) and offers a wide range of product development and support services to the pharmaceutical, biotechnology, and medical device industries. Nuvisan's expertise encompasses early and clinical development, drug trials, bioanalytical analysis, pharmaceutical analysis, quality control, stability testing, and the management of test specimens. By delivering both individual tests and comprehensive drug development programs, Nuvisan supports clients throughout the various stages of drug development, facilitating the advancement of new therapies and medical innovations.

CaliberMRI is a platform that includes brain, breast, prostate, and custom phantoms, and companion automated quality control software. They provide services that include quantitative MRI, qmri, phantoms, quantitative medicine, radiology, breast cancer, and calibration.

Iconovo is a Swedish device company that designs and licenses inhalation devices for pharmaceutical use. It develops multiple dry powder inhaler platforms, including a reservoir-based system, a capsule-based system, a unit-dose platform, and a pre-metered option, and it provides customized inhalation solutions to support both generic and innovative drug development. Founded in 2013 and headquartered in Lund, Iconovo collaborates with international pharmaceutical companies to advance inhaled medicines for respiratory conditions and other therapies. Its technology emphasizes safety, user-friendly design, and cost efficiency, with the aim of enabling development and commercialization of novel pharmaceuticals and vaccines and extending opportunities around patent expirations for established products. By offering protected inhaler technologies and development services, Iconovo seeks to serve customers across global markets.

Butterfly Network is a medical technology company developing handheld ultrasound systems that aim to democratize imaging and expand access to care. Its flagship device, a single-probe handheld system powered by Ultrasound-on-Chip semiconductor technology, enables whole-body diagnostic imaging with cloud-connected software and a mobile application, allowing clinicians to acquire, store, and analyze ultrasound data in real time. The platform supports workflow integration for hospitals and outpatient settings, and can image vascular, cardiac, abdominal, urological, fetal, gynecological, and musculoskeletal regions. The company envisions improving early detection and remote management of health conditions by enabling pocket-sized imaging capability and scalable ultrasound programs across healthcare facilities. Butterfly Network was founded with a mission to advance global health equity by increasing ultrasound access worldwide. The technology combines a compact hardware device with software to streamline acquisition, interpretation, and sharing of ultrasound information in clinical workflows.

Particles for Humanity is a company dedicated to transforming early-stage medical technologies into practical products aimed at improving the quality of life for individuals in low-resource settings. The company focuses on developing a portfolio of healthcare solutions that address critical issues such as vaccination and malnutrition. By employing a rigorous product development process that incorporates input from end-users, Particles for Humanity aims to create financially sustainable products that meet the specific needs of underserved populations. Through its innovative approach, the company seeks to empower individuals to combat serious health challenges and enhance their overall well-being.

Elarex, a Canadian healthcare technology company, specializes in developing and commercializing proprietary formulation technologies. Its flagship innovation, PT120, stabilizes biologicals, including live vaccines, enabling them to maintain full efficacy even when stored at 40°C, comparable to -80°C storage. This breakthrough allows for broader access to vaccines and biological drugs by facilitating transportation and storage in diverse environments, thereby enhancing global healthcare accessibility.

Mydawa operates an online pharmacy platform that connects patients directly with drug stores. It offers a wide range of high-quality medicines and wellness products, enabling consumers to purchase these affordably and conveniently via their mobile phones.

Philips is a global technology company focused on health technology and improving people’s health and well-being through meaningful innovation. It offers a broad portfolio spanning diagnostic imaging, ultrasound, image-guided therapy, patient monitoring, health informatics, and consumer health products, as well as home care devices. The company operates across three segments—diagnosis and treatment, connected care, and personal health—and also develops lighting and consumer electronics for everyday use. Philips serves hospitals, clinics, and homes, applying advanced technologies to support prevention, diagnosis, treatment, and home-based care while pursuing sustainable, user-centered solutions.

Particles for Humanity is a company dedicated to transforming early-stage medical technologies into practical products aimed at improving the quality of life for individuals in low-resource settings. The company focuses on developing a portfolio of healthcare solutions that address critical issues such as vaccination and malnutrition. By employing a rigorous product development process that incorporates input from end-users, Particles for Humanity aims to create financially sustainable products that meet the specific needs of underserved populations. Through its innovative approach, the company seeks to empower individuals to combat serious health challenges and enhance their overall well-being.

Ilara Health develops and distributes AI-powered diagnostic devices for primary care doctors serving rural and peri-urban communities in Africa, with its headquarters in Nairobi, Kenya. The compact devices connect to a proprietary software platform and electronic medical records, recording patient data to support accurate, affordable diagnostics at the point of care. The company aims to expand access to essential diagnostics by targeting the highly fragmented primary care infrastructure and delivering devices directly to clinicians, enabling clinicians to deliver timely, data-backed diagnostic services.

Particles for Humanity is a company dedicated to transforming early-stage medical technologies into practical products aimed at improving the quality of life for individuals in low-resource settings. The company focuses on developing a portfolio of healthcare solutions that address critical issues such as vaccination and malnutrition. By employing a rigorous product development process that incorporates input from end-users, Particles for Humanity aims to create financially sustainable products that meet the specific needs of underserved populations. Through its innovative approach, the company seeks to empower individuals to combat serious health challenges and enhance their overall well-being.

Almac Group is a global contract development and manufacturing organization that provides a comprehensive suite of services to pharmaceutical and biotechnology companies. Its offerings span research and development, biomarker discovery, active pharmaceutical ingredient production, formulation development, clinical trial supply, interactive voice response system technology, commercial‑scale manufacturing, and companion diagnostic development. Founded more than four decades ago, the privately held company employs over 4,500 professionals and is headquartered in Craigavon, Northern Ireland. Almac operates facilities across the United Kingdom, Ireland, the United States (Pennsylvania, North Carolina, California), and Asia (Singapore, Tokyo), and continually invests in advanced capabilities such as biocatalytic API synthesis, clinical trial data management, and the clinical supply chain. The organization also encompasses specialized units, including Almac Sciences, which offers analytical testing for drug substances and products, and Almac Discovery, a research‑driven oncology company focused on early‑stage drug discovery.

Credence MedSystems is a medical technology company specializing in drug delivery systems. It develops and manufactures safety syringes designed to enhance patient and caregiver safety, simplify commercialization paths for pharmaceutical partners, and reduce risks in healthcare settings.

Loop Medical, backed by Cerba Healthcare and the Bill & Melinda Gates Foundation, is developing a painless, needleless blood collection device. This modular platform, compatible with standard lab processes, aims to simplify blood sampling for both patients and healthcare professionals, making it more accessible and convenient. The technology, supported by Qloudlab's expertise in connected devices and biosensors, is designed to enhance healthcare outcomes by improving the blood collection process.

Particles for Humanity is a company dedicated to transforming early-stage medical technologies into practical products aimed at improving the quality of life for individuals in low-resource settings. The company focuses on developing a portfolio of healthcare solutions that address critical issues such as vaccination and malnutrition. By employing a rigorous product development process that incorporates input from end-users, Particles for Humanity aims to create financially sustainable products that meet the specific needs of underserved populations. Through its innovative approach, the company seeks to empower individuals to combat serious health challenges and enhance their overall well-being.

Butterfly Network is a medical technology company developing handheld ultrasound systems that aim to democratize imaging and expand access to care. Its flagship device, a single-probe handheld system powered by Ultrasound-on-Chip semiconductor technology, enables whole-body diagnostic imaging with cloud-connected software and a mobile application, allowing clinicians to acquire, store, and analyze ultrasound data in real time. The platform supports workflow integration for hospitals and outpatient settings, and can image vascular, cardiac, abdominal, urological, fetal, gynecological, and musculoskeletal regions. The company envisions improving early detection and remote management of health conditions by enabling pocket-sized imaging capability and scalable ultrasound programs across healthcare facilities. Butterfly Network was founded with a mission to advance global health equity by increasing ultrasound access worldwide. The technology combines a compact hardware device with software to streamline acquisition, interpretation, and sharing of ultrasound information in clinical workflows.

Scripps Research, established in 1924, is a prominent, not-for-profit biomedical research institution with campuses in La Jolla, CA, and Jupiter, FL. Employing around 3,000 people, it's renowned for its contributions to science and health, including breakthroughs in cancer, rheumatoid arthritis, and hemophilia treatments. The institute, which ranks among the top ten for its graduate program in biology and chemistry, is led by distinguished scientists, including Nobel laureates. Its drug discovery and development division, Calibr, collaborates with scientists to expedite the delivery of innovative medicines to patients. Scripps Research is recognized as a leader in biomedical innovation, ranking No.1 by the Nature Index.

Novartis is a global healthcare company based in Switzerland, providing innovative medicines and solutions to address evolving patient needs worldwide. With over 100,000 employees across 140 countries, they focus on discovering new treatments in areas such as oncology, immunology, neuroscience, and cardiovascular diseases.

NemoCare develops a comprehensive patient monitoring system using wireless wearable sensors, analytics, and big data. Its primary focus is on affordable, continuous monitoring for newborns in hospitals and at home, aiming to improve maternal and neonatal care.

Loop Medical, backed by Cerba Healthcare and the Bill & Melinda Gates Foundation, is developing a painless, needleless blood collection device. This modular platform, compatible with standard lab processes, aims to simplify blood sampling for both patients and healthcare professionals, making it more accessible and convenient. The technology, supported by Qloudlab's expertise in connected devices and biosensors, is designed to enhance healthcare outcomes by improving the blood collection process.

Atomo Diagnostics is an Australian company specializing in the research, design, development, and manufacture of medical devices for blood-based rapid testing, catering to both professional and consumer markets. Established in 2010 and headquartered in Leichhardt, Australia, the company offers its AtomoRapid RDT platforms, which are designed for a variety of blood-based lateral flow test assays. These devices are capable of screening for chronic conditions and detecting infectious diseases, including HIV. Atomo Diagnostics distinguishes itself by focusing on usability and user experience, addressing existing challenges in rapid diagnostic testing (RDT) through innovative design and patented features. This approach aims to enhance safety, accuracy, and reliability while minimizing user error. The company has a global presence, with operations in Europe, Asia, Africa, and Central and South America, and is led by an experienced management team dedicated to commercializing disruptive healthcare products.

Batavia Biosciences specializes in expediting the transition of biopharmaceutical products from discovery to clinical trials. They offer a range of services including candidate selection, production of research materials, process development (upstream and downstream), assay development, product characterization, and clinical manufacturing. Their expertise spans viral and bacterial vaccines, recombinant proteins, antibodies, and gene therapy products. Batavia Biosciences employs unique technologies like STEP® protein expression technology and SCOUT® high throughput process technology to accelerate timelines and reduce costs for their clients.

Affinivax, Inc. is a biotechnology company based in Lexington, Massachusetts, specializing in the development of vaccines using its innovative Multiple Antigen Presenting System (MAPS) technology. Founded in 2014, the company aims to enhance the protection against a range of infectious diseases that affect both children and adults globally. MAPS technology allows for the effective binding of protective polysaccharides and proteins within a single vaccine, inducing robust immune responses. Affinivax is advancing vaccine programs targeting significant pathogens, including Streptococcus pneumoniae, which contributes to considerable morbidity and mortality worldwide. The company leverages insights from leading experts in infectious diseases and has secured exclusive intellectual property rights related to its MAPS platform from Boston Children’s Hospital, with notable backing from the Bill & Melinda Gates Foundation.

Novavax is a biotechnology company focused on discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Its portfolio centers on nanoparticle vaccines using the Matrix-M adjuvant to elicit strong immune responses, including ResVax for respiratory syncytial virus delivered through maternal immunization and NanoFlu for seasonal influenza in older adults, with both candidates advancing through late-stage clinical trials. The company is advancing additional vaccine programs such as RSV vaccines for older adults and young children, as well as candidates against Ebola and a combined influenza and RSV vaccine. It collaborates with Takeda for NVX-CoV2373, a COVID-19 vaccine candidate, and operates globally via its development and commercialization platform. Founded in 1987 and headquartered in Gaithersburg, Maryland, Novavax pursues vaccines across multiple stages of clinical development to address urgent health needs.

Ceres Nanosciences specializes in the research, development, and commercialization of innovative sample preparation products based on its proprietary Nanotrap technology. This platform captures, enriches, and preserves biomarkers from various biofluid matrices, enabling early detection of diseases such as cancer, cardiac, and infectious diseases.

YourBio Health specializes in innovative blood sampling technologies. Their flagship product, Seventh Sense On Vivo™ platform, enables safe and painless diagnostic testing using proprietary Touch Activated Phlebotomy™ (TAP™) technology. This single-step process can be integrated with various diagnostic assays for rapid results, improving patient experience and accessibility to critical healthcare information.